Cargando…

Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial

BACKGROUND: Physical therapy and peritendinous hyaluronic acid (HA) injections have both shown promising results in the treatment of shoulder tendinopathies. However, the superiority of treatment combining physical therapy and HA is unclear. METHODS: Patients with ultrasound-confirmed supraspinatus...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores, César, Balius, Ramón, Álvarez, Guillermo, Buil, Miguel A., Varela, Luisa, Cano, Carlos, Casariego, Joaquín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459785/
https://www.ncbi.nlm.nih.gov/pubmed/28585109
http://dx.doi.org/10.1186/s40798-017-0089-9
_version_ 1783242023776550912
author Flores, César
Balius, Ramón
Álvarez, Guillermo
Buil, Miguel A.
Varela, Luisa
Cano, Carlos
Casariego, Joaquín
author_facet Flores, César
Balius, Ramón
Álvarez, Guillermo
Buil, Miguel A.
Varela, Luisa
Cano, Carlos
Casariego, Joaquín
author_sort Flores, César
collection PubMed
description BACKGROUND: Physical therapy and peritendinous hyaluronic acid (HA) injections have both shown promising results in the treatment of shoulder tendinopathies. However, the superiority of treatment combining physical therapy and HA is unclear. METHODS: Patients with ultrasound-confirmed supraspinatus tendinopathy were randomized to receive either physical therapy + subacromial HA injections or physical therapy only. Treatment efficacy was assessed using a Visual Analog Scale (VAS) for pain and an Activities of Daily Living (ADL) scale. Other measures were the number of rehabilitation sessions and days needed for recovery, the Tampa Scale for Kinesiophobia (TSK), and the physician and patient’s perception of efficacy and tolerability. Patients were followed up for 90 days. RESULTS: Overall, VAS and ADL scores showed a progressive decrease during the follow-up (P < 0.01 at all visits for both groups), without significant differences between groups. The TSK score decreased significantly more in the HA group than in the control group (3.6 vs. 2.4; P < 0.001). Patients in the control group needed more rehabilitation sessions (28 vs. 22 in the HA group; P = 0.006) and more days for returning to their pre-injury activity (32 vs. 20 in the HA group; P = 0.013). Both patients and investigators perceived higher efficacy in the HA group than in the control group (P = 0.034). Both treatments were safe and well tolerated. CONCLUSIONS: Subacromial HA injections combined with physical therapy have high efficacy in the treatment of supraspinatus tendinopathy, leading to an earlier return to pre-injury activity and the need for fewer rehabilitation sessions, which may benefit both patients and the healthcare system. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40798-017-0089-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5459785
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-54597852017-06-22 Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial Flores, César Balius, Ramón Álvarez, Guillermo Buil, Miguel A. Varela, Luisa Cano, Carlos Casariego, Joaquín Sports Med Open Original Research Article BACKGROUND: Physical therapy and peritendinous hyaluronic acid (HA) injections have both shown promising results in the treatment of shoulder tendinopathies. However, the superiority of treatment combining physical therapy and HA is unclear. METHODS: Patients with ultrasound-confirmed supraspinatus tendinopathy were randomized to receive either physical therapy + subacromial HA injections or physical therapy only. Treatment efficacy was assessed using a Visual Analog Scale (VAS) for pain and an Activities of Daily Living (ADL) scale. Other measures were the number of rehabilitation sessions and days needed for recovery, the Tampa Scale for Kinesiophobia (TSK), and the physician and patient’s perception of efficacy and tolerability. Patients were followed up for 90 days. RESULTS: Overall, VAS and ADL scores showed a progressive decrease during the follow-up (P < 0.01 at all visits for both groups), without significant differences between groups. The TSK score decreased significantly more in the HA group than in the control group (3.6 vs. 2.4; P < 0.001). Patients in the control group needed more rehabilitation sessions (28 vs. 22 in the HA group; P = 0.006) and more days for returning to their pre-injury activity (32 vs. 20 in the HA group; P = 0.013). Both patients and investigators perceived higher efficacy in the HA group than in the control group (P = 0.034). Both treatments were safe and well tolerated. CONCLUSIONS: Subacromial HA injections combined with physical therapy have high efficacy in the treatment of supraspinatus tendinopathy, leading to an earlier return to pre-injury activity and the need for fewer rehabilitation sessions, which may benefit both patients and the healthcare system. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40798-017-0089-9) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-06-05 /pmc/articles/PMC5459785/ /pubmed/28585109 http://dx.doi.org/10.1186/s40798-017-0089-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
Flores, César
Balius, Ramón
Álvarez, Guillermo
Buil, Miguel A.
Varela, Luisa
Cano, Carlos
Casariego, Joaquín
Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial
title Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial
title_full Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial
title_fullStr Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial
title_full_unstemmed Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial
title_short Efficacy and Tolerability of Peritendinous Hyaluronic Acid in Patients with Supraspinatus Tendinopathy: a Multicenter, Randomized, Controlled Trial
title_sort efficacy and tolerability of peritendinous hyaluronic acid in patients with supraspinatus tendinopathy: a multicenter, randomized, controlled trial
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459785/
https://www.ncbi.nlm.nih.gov/pubmed/28585109
http://dx.doi.org/10.1186/s40798-017-0089-9
work_keys_str_mv AT florescesar efficacyandtolerabilityofperitendinoushyaluronicacidinpatientswithsupraspinatustendinopathyamulticenterrandomizedcontrolledtrial
AT baliusramon efficacyandtolerabilityofperitendinoushyaluronicacidinpatientswithsupraspinatustendinopathyamulticenterrandomizedcontrolledtrial
AT alvarezguillermo efficacyandtolerabilityofperitendinoushyaluronicacidinpatientswithsupraspinatustendinopathyamulticenterrandomizedcontrolledtrial
AT builmiguela efficacyandtolerabilityofperitendinoushyaluronicacidinpatientswithsupraspinatustendinopathyamulticenterrandomizedcontrolledtrial
AT varelaluisa efficacyandtolerabilityofperitendinoushyaluronicacidinpatientswithsupraspinatustendinopathyamulticenterrandomizedcontrolledtrial
AT canocarlos efficacyandtolerabilityofperitendinoushyaluronicacidinpatientswithsupraspinatustendinopathyamulticenterrandomizedcontrolledtrial
AT casariegojoaquin efficacyandtolerabilityofperitendinoushyaluronicacidinpatientswithsupraspinatustendinopathyamulticenterrandomizedcontrolledtrial